BRAF and colorectal carcinoma: Thus, the canonical oncogenic p.V600E variant (c.1799T > A, rs113488022) was found in the vast majority of CRC patients, contrary to adenocarcinoma of the small intestine, where it represents only 10.3% of BRAF mutations [148].